RecruitingNot ApplicableNCT06120218

Tandem Occlusion After Emergent Stenting in Acute Ischemic Stroke

Tandem Occlusion After Emergent Stenting in Acute Ischemic Stroke: Preliminary Experience From a Vietnamese Comprehensive Stroke Centre


Sponsor

Can Tho Stroke International Services Hospital

Enrollment

110 participants

Start Date

Dec 1, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

In acute ischemic stroke due to tandem occlusion, the emergent stenting has recently become an endovascular treatment option combining with mechanical thrombectomy to achieve recanalization. However, the data on the beneficial endovascular management of tandem occlusion in two circulations is still limited. The purpose of our study was to compare the improvement of clinical outcome between two circulations after emergent stenting at 3 months.


Eligibility

Min Age: 19 YearsMax Age: 100 Years

Inclusion Criteria4

  • Age > 18 years old
  • Premorbid mRS < 2
  • NIHSS > 5
  • ASPECTS ≥ 5 or pc-ASPECTS ≥ 5

Exclusion Criteria2

  • Onset to treatment time > 24 hours
  • Loss to follow up after discharge

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREEmergent Stenting

Emergent Stenting in acute ischemic stroke caused by tandem occlusions


Locations(1)

Can Tho Stroke International Services Hospital

Can Tho, Vietnam

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06120218


Related Trials